OCT 08, 2019 5:00 AM PDT

Impact of global viral surveillance on diagnostic tools

Sponsored by: Abbott Diagnostics
C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Head of Infectious Disease Research, Abbott Diagnostics
    Biography
      Gavin A. Cloherty, graduated from the National University of Ireland, Galway, where he received his Ph.D. in molecular biology and a Bachelor of Science in microbiology and zoology. He provides scientific leadership in the area of infectious disease diagnostics by leading groundbreaking clinical studies on hepatitis and HIV. As one of the top experts in the field, his innovative research is changing the way infectious diseases are being diagnosed to help improve patient outcomes.

      Gavin has 20 years of experience with Abbott and leads a team of scientists in the study of HIV and hepatitis viral strain diversity through the Abbott's Global Viral Surveillance Program. In addition to HIV and hepatitis related discoveries, Gavin leads a team that recently identified unique hepatitis E recombinant strains in humans, uncovered unexpectedly high prevalence of hepatitis Delta in countries such as Cameroon, and identified strains of the newly discovered HPgV-2 in samples from around the world.

      Throughout his career Gavin has published numerous abstracts, posters and manuscripts. He has established numerous partnerships with commercial organizations, ministries of health and government agencies, including the Centers for Disease Control and Prevention (CDC). He is a member of numerous professional and scientific societies, including the International AIDS Society and the American Association for the Study of Liver Disease.

    Abstract:
    DATE:   October 8, 2019
    TIME:    5:00am PDT, 8am EDT, 2:00pm CEST
     
    When disease-causing viruses (e.g. hepatitis B) mutate, there is a risk of not only being unable to treat them with current medications, but also being unable to detect them in the first place. Therefore, viral genetic diversity has the potential to impact a vast number of healthcare touchpoints.
     
    Abbott is constantly searching for new ways to help improve people's health. A critical success factor involves monitoring retroviruses and hepatitis viruses from around the globe with a surveillance program, to help ensure laboratory tests continue to accurately detect divergent viruses, regardless of where they are acquired. Since 1994, Abbott's Global Viral Surveillance Program has been at the forefront of viral surveillance continually evolving to impact the development of next generation solutions.
     
    Learning Objectives:
    • Understand the evolution of the Global Viral Surveillance Program and find out what's new
    • Discover the impact of viral surveillance on past, present and future laboratory diagnostic tools 
    • Understand how you can get involved in the program
     
     
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
     

    Show Resources
    You May Also Like
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    NOV 18, 2019 7:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 7:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUL 31, 2019 9:00 AM PDT
    C.E. CREDITS
    JUL 31, 2019 9:00 AM PDT
    DATE: July 31, 2019TIME: 9:00am PT, 12:00pm ET The choroid plexus, which makes up the blood-cerebrospinal fluid barrier in the central nervous system (CNS), lines the ventricle...
    FEB 25, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    Loading Comments...
    Show Resources